Form D · Biotechnology
NeuroDex Inc
Natick, MA · CIK 0001801963
Offering snapshot reported May 2, 2023 · SEC filing
- Reported sold
- $60K Offering amount: $750K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 14, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 2, 2023 | Initial | $60,000 | No comparison | 1 | SEC filing |
| Aug 30, 2022 | Initial | $799,989 | No comparison | 3 | SEC filing |
| Feb 3, 2020 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-480584
Convertible Debt
Source: Form D, filed May 2, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Oded Biran | Director, Executive |
| Erez Eitan | Director, Executive |
| Gary Magnant | Director |
| Raphael Nir | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
27 Strathmore Rd.
Natick, MA, 01760
Natick, MA, 01760